These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9491705)

  • 1. [The lipid peroxidation and chemiluminescence indices of patients with erysipelas and concomitant diabetes mellitus].
    Frolov VM; Zelenyĭ II
    Lik Sprava; 1997; (5):82-4. PubMed ID: 9491705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pathogenetic characteristics and treatment of erysipelas in diabetics].
    Frolov VM; Zelenyĭ II
    Lik Sprava; 1997; (6):154-6. PubMed ID: 9589965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic disorders in erysipelas patients with concomitant diabetes mellitus].
    Zelenyĭ II; Vysotskiĭ AA; Chibisov LP
    Lik Sprava; 1997; (3):135-7. PubMed ID: 9377337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid peroxidation in patients with diabetes mellitus].
    Sukhanova LIa; Kulikova LA; Galenok VA
    Probl Endokrinol (Mosk); 1988; 34(2):16-7. PubMed ID: 3393499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific features of lipid atherogenic modification in patients with ischemic heart disease and diabetes mellitus].
    Syrkin AL; Azizova OA; Drinitsina SV; Solovi'eva NP; Frenkel' EE; Savchenkova AP; Kliuchnikova TI
    Klin Med (Mosk); 2001; 79(4):25-9. PubMed ID: 11496733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemiluminescence of erythrocytes of various age groups in patients with diabetes mellitus].
    Sukhanova LIa; Kamenskaia VV
    Lab Delo; 1989; (12):33-6. PubMed ID: 2483199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid peroxidation parameters and activities of lysosomal enzymes in patients with diabetes mellitus].
    Chugunova LG; Dubinina II
    Probl Endokrinol (Mosk); 1994; 40(5):9-11. PubMed ID: 7899451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipid peroxidation in patients with hypertension and renal hypertension against a background of diabetes mellitus].
    Kuznetsov NS; Abulela AM; Kulagin IuI; Neskromnyĭ VN; Babin IuF
    Lik Sprava; 1996; (5-6):117-8. PubMed ID: 9377373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
    Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
    J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The atherogenesis characteristics of diabetic patients].
    Prystupiuk OM
    Lik Sprava; 1999; (1):57-9. PubMed ID: 10423999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indicators of nonspecific resistance of the body in patients with erysipelas].
    Lipkovskaiia IV; Ermolin GA; Sokol AS; Pavlishin VV; Efremov AN
    Vrach Delo; 1989 Feb; (2):107-9. PubMed ID: 2711647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of chemiluminescence in predicting suppurative-inflammatory complications in erysipelas and tonsillitis].
    Frolov VM; Peresadin NA; Larionaov GM; Pinskiĭ LL; Pustovoĭ IuG
    Klin Lab Diagn; 1993; (3):29-31. PubMed ID: 8963534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemostatic studies in decompensated diabetes mellitus].
    Petrunova N; Genova V
    Vutr Boles; 1988; 27(5):43-6. PubMed ID: 3213038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of Reamberin in correction of oxidative stress syndrome in patients with phlegmonous and gangrenous erysipelas against the background of the 2 type diabetes mellitus].
    Zelenyĭ II; Frolov VM; Peresadin NA
    Vestn Khir Im I I Grek; 2012; 171(6):54-6, 58. PubMed ID: 23488264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The blood serum lipid spectrum in diabetes mellitus].
    Ibragimov TK
    Probl Endokrinol (Mosk); 1990; 36(5):33-4. PubMed ID: 2080139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The indices of the lipid peroxidation and desaturation of the blood serum in diabetes mellitus in children].
    Turkina TI; Marchenko LF; Zezerov AE; Pozniak TI; Martynova MI; Kiseleva EV
    Probl Endokrinol (Mosk); 1991; 37(4):13-5. PubMed ID: 1788182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of acute endotoxicosis in diabetic patients with surgical diseases requiring emergency intervention].
    Gusha AL; Tarasenko SV; Fedoseev AV
    Khirurgiia (Mosk); 1998; (8):36-9. PubMed ID: 9753936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid peroxidation in patients with type-1 diabetes mellitus].
    Starosel'tseva LK; Kosilova ES; Smurova TF; Narovlianskaia SE; Kravtsova IV
    Probl Endokrinol (Mosk); 1986; 32(1):19-22. PubMed ID: 3952071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of dyslipoproteinemias among diabetes mellitus patients].
    Kudriakova SV; Suntsov IuI; Slavina LS; Mazovetskiĭ AG
    Probl Endokrinol (Mosk); 1987; 33(2):13-6. PubMed ID: 3601885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus].
    Lapotnikov VA; Moiseev SI
    Ter Arkh; 1988; 60(9):31-5. PubMed ID: 3217876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.